AD Not Linked to Early CV Risk Markers - Top-Institutions - MDSpire

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

  • By

  • Kathryn Wighton

  • May 27, 2026

  • 5 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco Clinical and Translational Science Institute
    University of California, San Francisco Clinical and Translational Science Institute

    San Francisco, California

    Key Differentiators

    • Cardiology

  • #2

    SWEDEHEART
    SWEDEHEART

    Stockholm, Sweden

    Key Differentiators

    • Cardiology

  • #3

    UCC-SMART
    UCC-SMART

    Unknown, Unknown

    Key Differentiators

    • Cardiology

  • #4

    Coronary Artery Calcium Consortium
    Coronary Artery Calcium Consortium

    Unknown, Unknown

    Key Differentiators

    • Cardiology

  • #5

    National Child Development Study (NCDS)
    National Child Development Study (NCDS)

    London, United Kingdom

    Key Differentiators

    • Cardiology

Original Source(s)

AD Not Linked to Early CV Risk Markers

  • by Kathryn Wighton

  • May 27, 2026

Related Content

Baptist Health Heart & Vascular Care Hosts ECMO Boot Camp for Clinicians

Baptist Health Heart & Vascular Care recently hosted the BHSF–UPMC ECMO Boot Camp at the Education Center at Baptist Health Baptist Hospital.

  • by

  • May 26, 2026

  • 2 min
Non-Invasive Testing for Coronary Artery Disease

Dr. Uprety discusses the current role of non-invasive testing for coronary artery disease, highlighting evidence-based diagnostic strategies and the appropriate use of imaging modalities to improve early detection, risk stratification, and clinical decision-making.

  • May 18, 2026

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.